Keywords: zeneca, takes, charge, still, forecasts, top-end, despite

Zeneca Takes Charge, But Still At Forecasts' Top-End

Article | 29 January 1996

• Print This

Despite taking a charge of L60 million ($90.7 million) for restructuring and improving its pharmaceutical manufacturing and distribution activities, UK company ...

Enjoying this article? To continue reading you need to login or subscribe.